Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Selenium anti-cancer effects in JAMA study may not apply to women -- editorial.

This article was originally published in The Tan Sheet

Executive Summary

SELENIUM CANCER PREVENTION EFFECT IN WOMEN UNCLEAR based on a large, randomized trial of the trace element's effect on cancer incidence published in the Dec. 25 issue of the Journal of the American Medical Association, Graham Colditz, Brigham & Women's Hospital and Harvard Medical School, points out in an accompanying editorial. The study, conducted by Larry Clark, PhD, et al., University of Arizona, found that in a cohort of 1,312 patients, selenium supplementation reduced the incidence of and mortality from carcinomas of several sites.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel